Metraipolis › archive › dc_ef463dd80091
Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors — Europe PMC PMID:40815495
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40815495
- DOI
- 10.1007/s44313-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T15:00:16.999Z
- SHA-256 of the archived text
51f0029e47938b726f2d66a6c024fe7e4c18c934b7d1780ad5b16736e51a8a2a- Stable URL of this page
https://metraipolis.com/documento/dc_ef463dd80091
How to cite
Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors — Europe PMC PMID:40815495 — Europe PMC (en), https://europepmc.org/article/MED/40815495 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef463dd80091 (Metraipolis archive dc_ef463dd80091, sha256 51f0029e47938b726f2d66a6c024fe7e4c18c934b7d1780ad5b16736e51a8a2a)
BibTeX
@misc{dcef463dd80091,
title = {Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors — Europe PMC PMID:40815495},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40815495},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef463dd80091; sha256 51f0029e47938b726f2d66a6c024fe7e4c18c934b7d1780ad5b16736e51a8a2a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40815495. Agents can read the archived copy with the MCP tool read_document.